- Staat
- NC
- Alter
- 0,2
- Geschlecht
- M
- Eingang
- 04.03.2022
- Impfdatum
- 20.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cardiac arrest
Death
Hypoglycaemia
Pulse absent
Resuscitation
Symptomtext
Patient presented to the ED in cardiac arrest following morning after receiving 2 month vaccines previous afternoon. Per mom she last saw the child 3 hours prior to recognizing the patient to be pulseless. The baby sleeps in bassinet with their twin sibling. Patient mother states that she fed the child 3 hours previous and child appeared in no distress. On medic arrival patient was pulseless IO established. Patient found to be hypoglycemic and given D10 8 mL. Patient received three epi prior to hospital arrival. Protocol was pursued. Patient remained pulseless and asystolic the entire time. 43 minutes of CPR performed until time of death.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 07.08.2021
- Impfdatum
- 05.08.2021
- Beginn
- 07.08.2021
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood pressure decreased
Burning sensation
Cold sweat
Gaze palsy
Immediate post-injection reaction
Seizure
Skin discolouration
Vomiting
Symptomtext
Adverse reaction was immediate. Her eyes rolled back in her head and she convulsed four times. Had we not been next to her to hold her up, she would have fallen off of the table. It took a while for her to "come to" and then she proceeded to vomit several times. Her blood pressure dropped and her skin was clammy to the touch. Color was gone from her skin. She said she felt like her head was on fire. She was 90% better an hour later and was able to leave the clinic. She had a headache and jaw pain the rest of the day.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 10.05.2021
- Impfdatum
- 09.04.2021
- Beginn
- 09.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Loss of consciousness
Symptomtext
After completion of vaccinations patient passed out momentarily. Mom had patient supported and the RN grabbed the doctor. We laid patient down. Provided crackers and water. Patient began to improve. Patient was able to sit up in the chair after 2-3 minutes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Loratadine 10mg prn
- Allergien
- soap - rash
- Vorherige Impfungen
- dizzy after previous vaccine, but mother not sure which
- Staat
- TX
- Alter
- 0,5
- Geschlecht
- F
- Eingang
- 07.01.2021
- Impfdatum
- 28.12.2020
- Beginn
- 31.12.2020
- Tage bis Beginn
- 3,0
- Dosis
- 3
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Partial seizures
Seizure
Symptomtext
focal seizures, onset of which occured 3 days after her 3rd dose of Pentacel, PCV 13, Hepatitis B and Rotateq vaccines Patient also received Influenza vaccines Seizures are described as tilting of the neck to the left with jerky movements of the left arm and head This has occured multiple times, daily, 3-10 episodes per day Patient has been referred to pediatric neurology for further evaluation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Partial seizures
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Histex PD 0.938 mg/mL 0.33mL PO four times a day PRN for cough and congestion
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 0,8
- Geschlecht
- F
- Eingang
- 29.08.2022
- Impfdatum
- 22.06.2022
- Beginn
- 22.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Expired Vaccine given, Vaccine expired 6/1/22, given 6/22/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Fluoride
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 19.08.2022
- Impfdatum
- 11.08.2022
- Beginn
- 11.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patient received an expired dose of engerix-b; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 17-year-old male patient who received HBV (Engerix B) (batch number D423N, expiry date 1st June 2022) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis. On 11th August 2022, the patient received Engerix B and Engerix B Pre-Filled Syringe Device. On 11th August 2022, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-AUG-2022 Reporter's Comment: The reporter was a nurse. The reporter reported that the patient received an expired dose of Engerix-B. The reporter consented to follow up. Additional supportive information: The patient received a Engerix-B which was already expired, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 10,0
- Geschlecht
- F
- Eingang
- 03.08.2022
- Impfdatum
- 07.07.2022
- Beginn
- 07.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
expired dose of Engerix-B administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 10-year-old female patient who received HBV (Engerix B pediatric) (batch number D423N, expiry date 1st June 2022) for prophylaxis. On 7th July 2022, the patient received Engerix B pediatric. On 7th July 2022, unknown after receiving Engerix B pediatric, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional Information: GSK receipt date: 28-JUL-2022 Reporter's comments: Pharmacy resident reporting expired dose of Engerix-B administered on 7th July 2022 which expired on 1st June 2022. The adverse event report contained all details provided by the health care professional (HCP). The health care professional (HCP) gave consent for safety team to follow up. Additional Supportive Information: The patient received Engerix B pediatric beyond expiry date, which led to expired vaccine used. This case has been linked to the case US2022112346 reported by the same reporter.; Sender's Comments: US-GSK-US2022112346:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 10,0
- Geschlecht
- F
- Eingang
- 02.08.2022
- Impfdatum
- 07.07.2022
- Beginn
- 07.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
child was administered a vaccine that had expired over one month earlier on 6/1/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- tylenol Meltaway 80 mg oral tablet, Calcium carbonate (Tums) 500 oral chewable tablet
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 28.07.2022
- Impfdatum
- 14.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
received dose that had expired; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 17-year-old female patient who received HBV (Engerix B) (batch number D423N, expiry date 1st June 2022) for prophylaxis. On 14th July 2022, the patient received Engerix B. On 14th July 2022, unknown after receiving Engerix B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional Information: GSK receipt date: 15-Jul-2022 Reporters comment: The reporter consented to follow up. Additional Supportive Information: The patient received expired dose of Engerix B, which led to expired vaccine used. This case was linked with case US2022107251, reported by the same reporter.; Sender's Comments: US-GSK-US2022107251:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 12,0
- Geschlecht
- U
- Eingang
- 23.07.2022
- Impfdatum
- 14.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patient received on 14 Jul 2022 a dose of Engerix-B that had expired on 1 Jun 2022; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 12-year-old patient who received HBV (Engerix B) (batch number D423N, expiry date 1st June 2022) for prophylaxis. On 14th July 2022, the patient received Engerix B. On 14th July 2022, unknown after receiving Engerix B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional Information: GSK Receipt Date: 15-Jul-2022 Reporter's comments: The patient received the dose of Engerix-B on 14 July 2022 that had been expired on 01 June 2022. The consent to follow up was given. Additional Supportive Information: The patient received expired dose of Engerix B, which led to expired vaccine used. This case was linked with case US2022107249, reported by the same reporter.; Sender's Comments: US-GSK-US2022107249:Same reporter, same case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 23.06.2022
- Impfdatum
- 15.06.2022
- Beginn
- 15.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Administration of expired dose; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 4-year-old male patient who received HBV (Engerix B) (batch number d423n, expiry date 1st June 2022) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis. On 15th June 2022, the patient received Engerix B and Engerix B Pre-Filled Syringe Device. On 15th June 2022, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-JUN-2022 Reporter's Comments: The office manager reported that male patient received a dose of Engerix B on 15th June 2022 and the dose had expired on 1st June 2022. The reporter was consented to follow up. The Vaccine Administration Facility was the same as Primary Reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 19,0
- Geschlecht
- M
- Eingang
- 11.06.2022
- Impfdatum
- 06.06.2022
- Beginn
- 06.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Incorrect dose administered
Product administered to patient of inappropriate age
Symptomtext
Administered a dose that was expired; Administered an adult dose to a 19 years old patient; Administered an adult dose to a 19 years old patient; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 19-year-old male patient who received HBV (Engerix B adult) (batch number D423N, expiry date 1st June 2022) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis. On 6th June 2022, the patient received Engerix B adult and Engerix B Pre-Filled Syringe Device. On 6th June 2022, unknown after receiving Engerix B adult and Engerix B Pre-Filled Syringe Device, the patient experienced expired vaccine used, inappropriate age at vaccine administration and overdose. On an unknown date, the outcome of the expired vaccine used, inappropriate age at vaccine administration and overdose were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 6-June-2022 Reporter's comment: The pharmacist reported that they administered a dose of ENGERIX B adult that was expired to a patient. No other symptoms reported. The reporter consented to follow up. Additional Supportive Information: 19 Years old patient received a dose of ENGERIX B adult that was expired which led to expired vaccine used, inappropriate age at vaccine administration and overdose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 0,1
- Geschlecht
- F
- Eingang
- 11.06.2022
- Impfdatum
- 06.06.2022
- Beginn
- 06.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
administered an expired dose; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 1-month-old female patient who received HBV (Engerix B pediatric) (batch number D423N, expiry date 1st June 2022) for prophylaxis. On 6th June 2022, the patient received Engerix B pediatric. On 6th June 2022, unknown after receiving Engerix B pediatric, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional Information: GSK receipt date: 6-June-2022 Reporter's comment: The reporter administered an expired dose of ENGERIX B PEDS to a patient. No symptoms reporter. Reporter did not provide prescriber information for follow up. The reporter did not consent to follow-up. Additional Supportive Information: The patient was administered an expired dose of the Engerix B pediatric which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 20.08.2021
- Impfdatum
- 20.08.2021
- Beginn
- 20.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Ped Hep B was given instead of HPV given today. No adverse symptoms
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 26,0
- Geschlecht
- M
- Eingang
- 09.08.2021
- Impfdatum
- 07.07.2021
- Beginn
- 04.08.2021
- Tage bis Beginn
- 28,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Underdose
Symptomtext
Client was inadvertently given a Pediatric dose of Hep B as #2 dose in his series of 3 doses. The mistake was discovered by the clerk putting the information into the computer on August 4th, & was reported to the Administrator right away. The administering RN was notified, the Client was informed by phone, and an appointment made for Client to get an adult dose of Hep B according to his schedule. Client did not have any adverse effects from the Pediatric dose of Hep B; Client will have to have one extra shot (needle stick) of Hep B due to this error. Client will have a delay in completing the Hep B series.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 17.07.2021
- Impfdatum
- 07.07.2021
- Beginn
- 07.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Received an extra dose / on accident; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 18-year-old male patient who received HBV (Engerix B) (batch number D423N, expiry date 1st June 2022) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis. On 7th July 2021, the patient received the 4th dose of Engerix B (intramuscular) .5 ml and Engerix B Pre-Filled Syringe Device. On 7th July 2021, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that patient was fully vaccinated with Engerix-B and received an extra dose in accident,which led to extra dose administered. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 25,0
- Geschlecht
- M
- Eingang
- 13.05.2021
- Impfdatum
- 07.05.2021
- Beginn
- 07.05.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Underdose
Symptomtext
recieved a pediatric dose of Engerix B; recieved a pediatric dose of Engerix B; This case was reported by a other health professional via call center representative and described the occurrence of underdose in a 25-year-old male patient who received HBV (Engerix B pediatric) (batch number D423N, expiry date 1st June 2021) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis. On 7th May 2021, the patient received Engerix B pediatric and Engerix B Pre-Filled Syringe Device. On 7th May 2021, unknown after receiving Engerix B pediatric and Engerix B Pre-Filled Syringe Device, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: Medical assistant reported that male adult patient received on May 7th 2021 a pediatric dose of Engerix B, which led to underdose and adult use of a child product. The Vaccine Administration Facility is the same as Primary Reporter. The reporter did not consent to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 2,2
- Geschlecht
- F
- Eingang
- 05.05.2021
- Impfdatum
- 03.05.2021
- Beginn
- 03.05.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
No adverse event
Symptomtext
Pt had immunization appt at 8:45AM. Pt was accompanied by father. Father checked in with secretary, secretary gave Father standard immunizations forms and directed father and pt into room 1. This nurse was sitting at nurses station facing secretary. At no time did father state or produce any additional shot record besides what were already on file. This nurse reviewed pt immunization record to determine what vaccines were needed and gathered VIS sheets for shots needed based on the current vaccine record on file. This nurse took the VIS sheets into room to discuss with father. This nurse informed and discussed needed and optional vaccines (Hep A). Father was educated on Hep A and asked if would like to start the 2 dose series. Father was told them that pt would come back in 6 months for second and final dose then. Father agree to all vaccines and stated he had no questions or concerns. This nurse prepared vaccines and went back into the room. At this point, this nurse provided father with 2 copies of updated shot record. Father was by pt side at time of injections. After receiving vaccines father was informed he could make follow up appt for second Hep A before leaving if desired. When leaving father said good bye and was directed up to cashier's office. About 10:15AM mom calls in angry stating pt was given duplicate vaccines. Mom states she sent an updated shot with father for today's appt. Mom stated father came home with updated shot record from us. It was then she realized at today's appt pt received vaccines that were on the shot record from the pediatrician's office that father was to bring in. Mom states father told her he gave the shot record to the secretary. This nurse spoke with mom and was given an account of how the visit transpired. This nurse explained that this nurse was sitting at nurses station facing secretary's desk. At no time did pt's father state or produce updated shot record to the secretary or this nurse. At no time before, during, or after vaccines did father state there an additional vaccine record that existed. Nor, voiced a concern that the vaccines this nurse was giving today did not sound right. Mom states she wanted to file a complaint. This nurse notified the supervising nurse. Mother's name name and number were taken and she was informed a supervisor would be calling her back on the steps needed to file a complaint. Mom stated she understood.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- PT HAD NO ADVERS EVENTS AT TIME OF VACCINATION OR AT HOME FOLLOWING.
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 25.01.2021
- Impfdatum
- 08.01.2021
- Beginn
- 08.01.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Underdose
Symptomtext
patient was administered a .5ml doe instead of a 1ml
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -